NCT04004988View on ClinicalTrials.gov

A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

August 19, 2019

Primary Completion Date

December 16, 2019

Study Completion Date

December 16, 2019

Conditions
Healthy
Interventions
DRUG

Tirzepatide

Administered SC

DEVICE

Prefilled syringe (PFS)

PFS used to administer tirzepatide

DEVICE

Auto-injector (AI)

AI used to administer tirzepatide

Trial Locations (1)

138623

Lilly Nus Centre for Clin Pharmacology, Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04004988 - A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants | Biotech Hunter | Biotech Hunter